Home / Cardiovascular system / Candesartan and Diuretics
ATC C09DA06 · Agents Acting On The Renin-Angiotensin System
Candesartan and Diuretics shortage
As of 31 Oct 2026, Candesartan and Diuretics has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 10 products.
Countries3/5
Products10packs or presentations
Short since12 Dec 20223.9 years ago
Earliest return24 Nov 2026company estimate
No return date5products
Main reasonManufacturing problem
Timeline
ItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | CANDESARTAN E IDROCLOROTIAZIDE ZENTIVA ITALIA | ZENTIVA ITALIA S.R.L. | 12 Dec 2022 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | CANDESARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 9 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | CANDESARTAN E IDROCLOROTIAZIDE MYLAN GENERICS | MYLAN S.P.A. | 15 May 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | CANDESARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 17 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | CANDESARTAN/HIDROCLOROTIAZIDA VIATRIS 16 MG/12,5 MG COMPRIMIDOS EFG, 28 comprimidos | Viatris Limited | 5 Apr 2026 | 8 Mar 2027 | Not stated |
| ES | CANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORMON 8 MG/12.5 MG COMPRIMIDOS EFG, 28 comprimidos | Laboratorios Normon S.A. | 12 Oct 2026 | 24 Nov 2026 | Not stated |
| ES | CANDESARTAN CILEXETILO/HIDROCLOROTIAZIDA NORMON 32 MG/12.5 MG COMPRIMIDOS EFG , 28 comprimidos | Laboratorios Normon S.A. | 27 Oct 2026 | 24 Nov 2026 | Not stated |
| AT | Blopress Plus 32 mg/25 mg - Tabletten, 28 Stück | Cheplapharm Arzneimittel GmbH | 6 Dec 2025 | 5 Dec 2028 | Commercial decision or withdrawal Vorübergehende Einstellung des Inverkehrbringens |
| AT | Blopress Plus 32 mg/12,5 mg - Tabletten, 28 Stück | Cheplapharm Arzneimittel GmbH | 9 Apr 2026 | 8 Apr 2029 | Commercial decision or withdrawal Vorübergehende Einstellung des Inverkehrbringens |
| AT | Candesartan/HCT 1A Pharma 32 mg/12,5 mg - Tabletten, 30 Stück | 1 A Pharma GmbH | 27 Oct 2026 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.